· Original article
ELS shares fall 4.5% to $59.16
ELS shares fell 4.5% to $59.16 on October 21, 2026, with a trailing P/E of 28.8 times versus a five-year median of 39.1 times.
FINANCEVELIX / News
Listed companies, earnings, corporate developments and equity markets. Company and asset tags identify the subjects of a story.
Choose topics to see up to three latest articles per topic in your account.
Your topic choices are private to your account. No email or push notifications.
Please wait…
Read the original source and publication date in each article.
Results: 4,112 · Page 332 / 343
· Original article
ELS shares fell 4.5% to $59.16 on October 21, 2026, with a trailing P/E of 28.8 times versus a five-year median of 39.1 times.
· Original article
On Holding shares closed at $34.22 on October 21, 2026, down 3.4%, with a trailing P/E of 22.9 times.
· Original article
Amkor shares rose 4.9% to $43.73 on October 21, 2026, but remained down 16.2% over the past month.
· Original article
TTM shares rose 7.0% to $102.15 on October 21, 2026, remaining down 17.6% over the past month but up 80.2% year over year.
· Original article
Lululemon shares fell 3.4% on October 21, 2026, bringing their year-to-date decline to 53.5%.
· Original article
Enlight shares rose 3.4% to $71.83 on October 21, 2026. Insider share sales totaled $30.8 million over the preceding 12 months.
· Original article
AEIS shares rose 3.3% to $247.55 on October 21, 2026, bringing their year-to-date gain to 18.4%.
· Original article
10x Genomics shares rose 5.8% to $75.59 on October 21, 2026, extending gains of 363.5% year to date.
· Original article
Côté Gold delivered 64,400 attributable ounces in Q3, with Iamgold expecting higher fourth-quarter output after improved mining and milling performance.
· Original article
Qiagen takeover offer values the company at about €10.8 billion including net debt, with board backing and completion expected by mid-2027.
· Original article
Tesla plans to build 10,000–20,000 humanoid robots for Optimus Academy training, aiming to address a shortage of large-scale performance data.
· Original article
Qiagen outlook guidance for 2026 has been suspended pending its EQT transaction, and the company will skip its third-quarter earnings call.
Charts and market data by TradingView. Availability and delays vary by exchange.